Upcoming Events
Log In
Pricing
Free Trial

PI‐RADS Assessment for DCE

HIDE
PrevNext

0:00

Now I'd like to talk to you briefly about dynamic

0:04

contrast enhanced MRI

0:05

and there is some debate about its value

0:08

and its need, um, across the pond.

0:11

Our, our friends in Germany produced a, a fairly large study

0:14

that showed there was very little change in the PY RADS

0:18

grading and the overall outcomes of a patient with dynamic

0:21

contrast enhanced MRI.

0:23

Others believe that it,

0:24

it can be invaluable in certain circumstances,

0:27

and you can read about those circumstances in the PY Rads

0:32

V 2.1 document whose link is

0:35

provided in this series of vignettes.

0:37

So a negative enhancement pattern.

0:39

After you inject

0:41

and remember, you should be producing dynamic

0:44

contrast enhanced images on A 3D GRE

0:48

in the axial projection.

0:50

And then each dynamic temporal

0:53

slice should be less than 12 seconds.

0:55

We tend to average around seven

0:57

or eight seconds per dynamic temporal slice.

1:01

So negative, no early

1:03

or contemporaneous enhancement, that's easy

1:07

or diffuse multifocal enhancement

1:10

that does not correspond to

1:13

any focal finding on a teach two weighted image

1:15

that makes sense, or there's no focal DWI restriction

1:20

or focal enhancement corresponding to a lesion demonstrating

1:24

features of BPH.

1:26

In other words, there is enhancement corresponding

1:28

to a lesion, but that's a typical say,

1:31

BPH nodule on the T two weighted image.

1:35

And in the peripheral zone, those are frequently,

1:38

if they're round, they're gonna be extruded BPH nodules.

1:41

So you have to go back. If you see a nodule in the

1:43

peripheral zone that's enhancing, go back

1:46

and make sure that you don't have the neck

1:48

of the nodule coming out of the transitional zone,

1:51

because this is a very important pitfall

1:53

that can lead you into the over-diagnosis of cancer.

1:58

Now, what's a positive score?

2:01

A positive score is when you have focal

2:04

and earlier than the other tissues enhancement.

2:08

And this corresponds

2:10

to a suspicious finding on the T two weighted image

2:15

or the DWI.

2:17

Now, in some respects, this is a lot like breast imaging.

2:20

You know, if you have phase number one, all of a sudden pop,

2:24

you have a quick rapid enhancement in the first

2:27

7, 8, 12 seconds after injection,

2:31

before anything else appears.

2:33

And it matches up with say, a T two weighted abnormality

2:38

that's lent deform in the transitional zone

2:41

and kind of smears the tissues like a bagel.

2:44

Or you have a nodule in the, in the peripheral zone

2:47

that is not an extruded BPH nodule and

2:51

or you have DWI restriction along with that

2:55

or associated with that area of enhancement.

2:59

You've got a positive. Now, when can this be valuable?

3:02

It's valuable when you're noodling around a PI RADS three

3:07

on your by parametric assessment.

3:09

In other words, you've used the T two, you've used the TDWI

3:13

and you've come up with a PI RADS three designation.

3:16

If you have this additional dynamic enhanced, uh,

3:21

sequence and it's positive, then it's a three

3:26

plus one or it's a four, so it would become a PI RADS four,

3:30

and many people use it that way.

3:33

Let's move on, shall we?

Report

Editorial Note

Faculty

Stephen J Pomeranz, MD

Chief Medical Officer, ProScan Imaging. Founder, MRI Online

ProScan Imaging

John F. Feller, MD

Chief Medical Officer, HALO Diagnostics. Medical Director & Founder, Desert Medical Imaging. Chief of Radiology, American Medical Center, Shanghai, China.

HALO Diagnostics

Tags

Prostate/seminal vesicles

Oncologic Imaging

Neoplastic

MRI

Genitourinary (GU)

Body